Related references
Note: Only part of the references are listed.Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
Niels F. Jensen et al.
MOLECULAR ONCOLOGY (2015)
Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease
Massimiliano G. Bianchi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Glutathione synthesis
Shelly C. Lu
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
Radoslaw Januchowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
Glutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation
Ryota Kimura et al.
BMC CANCER (2013)
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer
Lucia Cortejoso et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2013)
The SLC1 high-affinity glutamate and neutral amino acid transporter family
Yoshikatsu Kanai et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Anguraj Sadanandam et al.
NATURE MEDICINE (2013)
MECHANISMS OF GLUTAMATE TRANSPORT
Robert J. Vandenberg et al.
PHYSIOLOGICAL REVIEWS (2013)
The Na+/H+ exchanger NHE1, but not the Na+, HCO3- cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2
Gitte Lauritzen et al.
CANCER LETTERS (2012)
Mislocalization of the exitatory amino-acid transporters (EAATs) in human astrocytoma and non-astrocytoma cancer cells: effect of the cell confluence
Karine Varini et al.
JOURNAL OF BIOMEDICAL SCIENCE (2012)
Molecular Predictors of Response to Chemotherapy in Colorectal Cancer
Rodrigo Dienstmann et al.
CANCER JOURNAL (2011)
Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer
Wei Chua et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Glutamate Transport Decreases Mitochondrial pH and Modulates Oxidative Metabolism in Astrocytes
Guillaume Azarias et al.
JOURNAL OF NEUROSCIENCE (2011)
In vitro drug responses in primary and metastatic colorectal cancers
Eugene Mechetner et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1
Anders A. Jensen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
Christopher A. Larson et al.
MOLECULAR PHARMACOLOGY (2009)
Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1
Helen H. W. Chen et al.
MOLECULAR PHARMACOLOGY (2008)
The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth
M. S. Kim et al.
ONCOGENE (2008)
Induction of group VIA phospholipase A2 activity during in vitro ischemia in C2C12 myotubes is associated with changes in the level of its splice variants
K. A. Poulsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Autocrine glutamate signaling promotes glioma cell invasion
Susan A. Lyons et al.
CANCER RESEARCH (2007)
P53 dependent and independent sensitivity to oxaliplatin of colon cancer cells
Florent Toscano et al.
BIOCHEMICAL PHARMACOLOGY (2007)
The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma
Takayuki Harada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse
K Aoyama et al.
NATURE NEUROSCIENCE (2006)
A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake
A Vallejo-Illarramendi et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
Membrane transporters and channels:: Role of the transportome in cancer chemosensitivity and chemoresistance
Y Huang et al.
CANCER RESEARCH (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay
AA Jensen et al.
BIOCHEMICAL PHARMACOLOGY (2004)
ONCOMINE: A cancer microarray database and integrated data-mining platform
DR Rhodes et al.
NEOPLASIA (2004)
Glutamate antagonists limit tumor growth
W Rzeski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Syntheses of optically pure β-hydroxyaspartate derivatives as glutamate transporter blockers
K Shimamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Share Paper
